Breathalyzer for COVID-19 detection in military settings
A Prospective, Non-interventional, Observational Clinical Validation Study to Analytically Validate the A&M Breathalyzer PROTECT Kiosk Breath Capture System.
This study is testing a new breathalyzer tool to see if it can quickly and reliably detect COVID-19 in military settings, helping to keep soldiers healthy and ready.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 89 Years |
| Sex | All |
| Sponsor | The Geneva Foundation Academic / other |
| Locations | 1 site (Fort Sam Houston, Texas) |
| Trial ID | NCT06402318 on ClinicalTrials.gov |
What this trial studies
This observational study aims to optimize and operationalize the A&M Breathalyzer PROTECT Kiosk for the passive detection of COVID-19 in military environments. Conducted at Brooke Army Medical Center, the study will evaluate the effectiveness of this innovative diagnostic tool in identifying both asymptomatic and symptomatic individuals. The research involves collaboration between military medical professionals and biotechnology experts to assess the kiosk's capabilities and adapt it for various operational scenarios. The goal is to enhance rapid and reliable COVID-19 diagnostics to improve military readiness and reduce the impact of respiratory infections.
Who should consider this trial
Good fit: Ideal candidates for this study include asymptomatic and symptomatic individuals aged 18 and older who are undergoing standard COVID-19 screening at Brooke Army Medical Center.
Not a fit: Patients under 18 years old or those unable to comply with study procedures will not benefit from this study.
Why it matters
Potential benefit: If successful, this technology could provide rapid and reliable COVID-19 detection, enhancing the health and operational readiness of military personnel.
How similar studies have performed: While there have been various studies on COVID-19 diagnostics, the specific use of a breathalyzer for passive detection in military settings is a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Asymptomatic and symptomatic individuals 18 years and older * Receiving standard COVID-19, Flu and/or RSV screening and testing at BAMC * Do not have to be diagnosed with SARS-CoV-19 (COVID-19) but only be screened * Ability to understand consent Exclusion Criteria: * Any individual under age of 18 * Anyone unable to comply (or be assisted) with study procedures * Anyone not able to provide temperature thermal scan, and/or perform exhaled breath for approximately 8 seconds
Where this trial is running
Fort Sam Houston, Texas
- Brooke Army Medical Center — Fort Sam Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Tony Yuan, PhD — Uniformed Services University of the Health Sciences (USUHS)
- Study coordinator: Tony Yuan, PhD
- Email: tony.yuan@usuhs.edu
- Phone: 214-292-0508
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.